7. Behandling

Abou-Alfa, G. K., Geschwind, J. F., Choti, M., & d'Angelica, M. I. (2015). Consensus conference on intrahepatic cholangiocarcinoma. HPB, 17(8), 661-3.

Abou-Alfa, G. K., Sahai, V., Hollebecque, A., Vaccaro, G., Melisi, D., Al-Rajabi, R., Paulson, A. S., Borad, M. J., ... Vogel, A. (2020). Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study. Lancet Oncology, 21(5), 671-684.

Aloia, T. A., Járufe, N., Javle, M., Maithel, S. K., Roa, J. C., Adsay, V., Coimbra, F. J., & Jarnagin, W. R. (2015). Gallbladder cancer: expert consensus statement. HPB, 17(8), 681-90.

AMMF (2022). ACTICCA-1 [pågående studie]. [nettdokument]. Essex: AMMF. Hentet 06. mai 2024 fra https://ammf.org.uk/acticca-1/

Bagante, F., Gani, F., Spolverato, G., Xu, L., Alexandrescu, S., Marques, H. P., Lamelas, J., Aldrighetti, L., ... Pawlik, T. M. (2015). Intrahepatic Cholangiocarcinoma: Prognosis of Patients Who Did Not Undergo Lymphadenectomy. Journal of the American College of Surgeons, 221(6), 1031-40.e1-4.

Bridgewater, J., Fletcher, P., Palmer, D. H., Malik, H. Z., Prasad, R., Mirza, D., Anthony, A., Corrie, P., ... Primrose, J. (2022). Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study. Journal of Clinical Oncology, 40(18), 2048-2057.

Bridgewater, J., Galle, P. R., Khan, S. A., Llovet, J. M., Park, J. W., Patel, T., Pawlik, T. M., & Gores, G. J. (2014). Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. Journal of Hepatology, 60(6), 1268-89.

Buettner, S., Ten Cate, D. W. G., Bagante, F., Alexandrescu, S., Marques, H. P., Lamelas, J., Aldrighetti, L., Gamblin, T. C., ... Koerkamp, B. G. (2019). Survival after Resection of Multiple Tumor Foci of Intrahepatic Cholangiocarcinoma. Journal of Gastrointestinal Surgery, 23(11), 2239-2246.

Conci, S., Ruzzenente, A., Viganò, L., Ercolani, G., Fontana, A., Bagante, F., Bertuzzo, F., Dore, A., ... Guglielmi, A. (2018). Patterns of Distribution of Hepatic Nodules (Single, Satellites or Multifocal) in Intrahepatic Cholangiocarcinoma: Prognostic Impact After Surgery. Annals of Surgical Oncology, 25(12), 3719-3727.

Di Martino, M., Koh, Y. X., Syn, N., Min Chin, K., Fernando, B., Sánchez Velázquez, P., Manzoni, A., Benedetti Cacciaguerra, A., ... Ielpo, B. (2022). It is the lymph node ratio that determines survival and recurrence patterns in resected distal cholangiocarcinoma. A multicenter international study. European Journal of Surgical Oncology, 48(7), 1576-1584.

Doebele, R. C., Drilon, A., Paz-Ares, L., Siena, S., Shaw, A. T., Farago, A. F., Blakely, C. M., Seto, T., ... Demetri, G. D. (2020). Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials. Lancet Oncology, 21(2), 271-282.

Ebata, T., Mizuno, T., Yokoyama, Y., Igami, T., Sugawara, G., & Nagino, M. (2018). Surgical resection for Bismuth type IV perihilar cholangiocarcinoma. British Journal of Surgery, 105(7), 829-838.

Edeline, J., Lamarca, A., McNamara, M. G., Jacobs, T., Hubner, R. A., Palmer, D., Groot Koerkamp, B., Johnson, P., ... Valle, J. W. (2021). Locoregional therapies in patients with intrahepatic cholangiocarcinoma: A systematic review and pooled analysis. Cancer Treatment Reviews, 99, 102258.

Edeline, J., Benabdelghani, M., Bertaut, A., Watelet, J., Hammel, P., Joly, J. P., Boudjema, K., Fartoux, L., ... Phelip, J. M. (2019). Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study. Journal of Clinical Oncology, 37(8), 658-667.

Esnaola, N. F., Meyer, J. E., Karachristos, A., Maranki, J. L., Camp, E. R., & Denlinger, C. S. (2016). Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer, 122(9), 1349-69.

Giuliante, F., Ardito, F., Guglielmi, A., Aldrighetti, L., Ferrero, A., Calise, F., Giulini, S. M., Jovine, E., ... Nuzzo, G. (2016). Association of Lymph Node Status With Survival in Patients After Liver Resection for Hilar Cholangiocarcinoma in an Italian Multicenter Analysis. JAMA surgery, 151(10), 916-922.

Greenblatt, D. Y., Kelly, K. J., Rajamanickam, V., Wan, Y., Hanson, T., Rettammel, R., Winslow, E. R., Cho, C. S., & Weber, S. M. (2011). Preoperative factors predict perioperative morbidity and mortality after pancreaticoduodenectomy. Annals of Surgical Oncology, 18(8), 2126-2135.

Groot Koerkamp, B., Wiggers, J. K., Allen, P. J., Besselink, M. G., Blumgart, L. H., Busch, O. R., Coelen, R. J., D'Angelica, M. I., ... van Gulik, T. M. (2015). Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection. Journal of the American College of Surgeons, 221(6), 1041-9.

Guglielmi, A., Ruzzenente, A., Bertuzzo, F., & Iacono, C. (2013). Assessment of nodal status for perihilar cholangiocarcinoma location, number, or ratio of involved nodes. Hepatobiliary surgery and nutrition, 2(5), 281-3.

Hameed, A., Pang, T., Chiou, J., Pleass, H., Lam, V., Hollands, M., Johnston, E., Richardson, A., & Yuen, L. (2016). Percutaneous vs. endoscopic pre-operative biliary drainage in hilar cholangiocarcinoma - a systematic review and meta-analysis. HPB, 18(5), 400-10.

Hartog, H., Ijzermans, J. N., van Gulik, T. M., & Groot Koerkamp, B. (2016). Resection of Perihilar Cholangiocarcinoma. Surgical Clinics of North America, 96(2), 247-67.

Hosokawa, I., Takayashiki, T., Kuboki, S., Takano, S., Togasaki, K., Miyazaki, M., & Ohtsuka, M. (2023). Prognostic impact of proximal ductal margin status in perihilar cholangiocarcinoma according to the presence or absence of lymph node metastasis. Surgery, 174(1), 11-20.

Jansson, H., Villard, C., Nooijen, L. E., Ghorbani, P., Erdmann, J. I., & Sparrelid, E. (2023). Prognostic influence of multiple hepatic lesions in resectable intrahepatic cholangiocarcinoma: A systematic review and meta-analysis. European Journal of Surgical Oncology, 49(4), 688-699.

Kelley, R. K., Ueno, M., Yoo, C., Finn, R. S., Furuse, J., Ren, Z., Yau, T., Klümpen, H. J., ... Vogel, A. (2023). Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet, 401(10391), 1853-1865.

Kelly, K. J., Dukleska, K., Kuk, D., Kingham, T. P., D'Angelica, M. I., DeMatteo, R. P., Allen, P. J., Jarnagin, W. R., & Fong, Y. (2014). Prognostic significance of the highest peripancreatic lymph node in biliary tract adenocarcinoma. Annals of Surgical Oncology, 21(3), 979-85.

Kwon, W., Kim, H., Han, Y., Hwang, Y. J., Kim, S. G., Kwon, H. J., Vinuela, E., Járufe, N., ... Jang, J. Y. (2020). Role of tumour location and surgical extent on prognosis in T2 gallbladder cancer: an international multicentre study. British Journal of Surgery, 107(10), 1334-1343.

Kwon, H. J., Kim, S. G., Chun, J. M., Lee, W. K., & Hwang, Y. J. (2014). Prognostic factors in patients with middle and distal bile duct cancers. World Journal of Gastroenterology, 20(21), 6658-65.

Lang, H. (2021). Should all intrahepatic cholangiocarcinomas receive neoadjuvant chemotherapy before resection?. British Journal of Surgery, 108(6), 598-599.

(2021). Cancer in Norway 2020: cancer incidence, mortality, survival and prevalence in Norway Oslo: Cancer Registry of Norway. Hentet fra https://www.kreftregisteret.no/globalassets/cancer-in-norway/2020/cin-2020.pdf

Le Roy, B., Gelli, M., Pittau, G., Allard, M. A., Pereira, B., Serji, B., Vibert, E., Castaing, D., ... Sa Cunha, A. (2018). Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma. British Journal of Surgery, 105(7), 839-847.

Lee, H., Choi, D. W., Park, J. Y., Youn, S., Kwon, W., Heo, J. S., Choi, S. H., & Jang, K. T. (2015). Surgical Strategy for T2 Gallbladder Cancer According to Tumor Location. Annals of Surgical Oncology, 22(8), 2779-86.

Liang, L., Li, C., Wang, M. D., Xing, H., Diao, Y. K., Jia, H. D., Lau, W. Y., Pawlik, T. M., ... Yang, T. (2021). The value of lymphadenectomy in surgical resection of perihilar cholangiocarcinoma: a systematic review and meta-analysis. International Journal of Clinical Oncology, 26(9), 1575-1586.

Luvira, V., Satitkarnmanee, E., Pugkhem, A., Kietpeerakool, C., Lumbiganon, P., & Pattanittum, P. (2021). Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma. Cochrane Database of Systematic Reviews, 9(9), CD012814.

Mansour, J. C., Aloia, T. A., Crane, C. H., Heimbach, J. K., Nagino, M., & Vauthey, J. N. (2015). Hilar cholangiocarcinoma: expert consensus statement. HPB, 17(8), 691-9.

Mantel, H. T., Westerkamp, A. C., Sieders, E., Peeters, P. M., de Jong, K. P., Boer, M. T., de Kleine, R. H., Gouw, A. S., & Porte, R. J. (2016). Intraoperative frozen section analysis of the proximal bile ducts in hilar cholangiocarcinoma is of limited value. Cancer medicine, 5(7), 1373-80.

Masoud, S. J., Rhodin, K. E., Kanu, E., Bao, J., Eckhoff, A. M., Bartholomew, A. J., Howell, T. C., Aykut, B., ... Lidsky, M. E. (2023). Comparing Survival After Resection, Ablation, and Radiation in Small Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology, 30(11), 6639-6646.

Morine, Y., & Shimada, M. (2015). The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics. Journal of Gastroenterology, 50(9), 913-27.

Mosconi, C., Solaini, L., Vara, G., Brandi, N., Cappelli, A., Modestino, F., Cucchetti, A., & Golfieri, R. (2021). Transarterial Chemoembolization and Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma-a Systemic Review and Meta-Analysis. Cardiovascular and Interventional Radiology, 44(5), 728-738.

Moustafa, M., Fasolo, E., Bassi, D., D'Amico F, E., Gringeri, E., Pawlik, T. M., & Cillo, U. (2020). The impact of liver resection on survival for locally advanced intrahepatic cholangiocarcinoma tumors: A propensity score analysis. European Journal of Surgical Oncology, 46(4 Pt A), 632-637.

Nakachi, K., Ikeda, M., Konishi, M., Nomura, S., Katayama, H., Kataoka, T., Todaka, A., Yanagimoto, H., ... Furuse, J. (2023). Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet, 401(10372), 195-203.

Oh, D. Y., Lee, K. H., Lee, D. W., Yoon, J., Kim, T. Y., Bang, J. H., Nam, A. R., Oh, K. S., ... Kim, J. W. (2022). Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study. Lancet Gastroenterology & hepatology, 7(6), 522-532.

Olthof, P. B., Franssen, S., van Keulen, A. M., van der Geest, L. G., Hoogwater, F. J. H., Coenraad, M., van Driel, L., Erdmann, J. I., ... Groot Koerkamp, B. (2023). Nationwide treatment and outcomes of intrahepatic cholangiocarcinoma. HPB, 25(11), 1329-1336.

Oslo universitetssykehus (2020). TESLA 1-studien: Levertransplantasjon hos pasienter med ikke-operabel kreft i gallegangene i leveren [pågående studie]. [nettdokument]. Oslo: Oslo universitetssykehus. Hentet 06. mai 2024 fra https://www.oslo-universitetssykehus.no/kliniske-studier/levertransplantasjon-hos-pasienter-med-ikke-operabel-kreft-i-gallegangene-i-leveren/

Oslo universitetssykehus (2021). TESLA 2-studien: Levertransplantasjon hos pasienter med kreft i gallegangene utenfor leveren [pågående studie]. [nettdokument]. Oslo: Oslo universitetssykehus. Hentet 06. mai 2024 fra https://www.oslo-universitetssykehus.no/kliniske-studier/levertransplantasjon-hos-pasienter-med-kreft-i-gallegangene-utenfor-leveren/

Primrose, J. N., Fox, R. P., Palmer, D. H., Malik, H. Z., Prasad, R., Mirza, D., Anthony, A., Corrie, P., ... Bridgewater, J. (2019). Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncology, 20(5), 663-673.

Qadan, M., & Kingham, T. P. (2016). Technical Aspects of Gallbladder Cancer Surgery. Surgical Clinics of North America, 96(2), 229-45.

Rassam, F., Roos, E., van Lienden, K. P., van Hooft, J. E., Klümpen, H. J., van Tienhoven, G., Bennink, R. J., Engelbrecht, M. R., ... van Gulik, T. M. (2018). Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience. Langenbecks Archives of Surgery, 403(3), 289-307.

Schimizzi, G. V., Jin, L. X., Davidson, J. T. t., Krasnick, B. A., Ethun, C. G., Pawlik, T. M., Poultsides, G., Tran, T., ... Fields, R. C. (2018). Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium. HPB, 20(4), 332-339.

Sekretariatet for nye metoder (25. november 2022). Retningslinje for bruk av nye legemidler før markedsføringstillatelse (compassionate use). [nettressurs]. Hamar: nyemetoder.no. Hentet 28. november 2022 fra https://nyemetoder.no/om-systemet/retningslinje-for-bruk-av-nye-legemidler-for-markedsforingstillatelse-compassionate-use

Suzuki, S., Shimoda, M., Shimazaki, J., Maruyama, T., Oshiro, Y., Nishida, K., Kuroda, J., Miyoshi, K., ... Harada, N. (2019). Number of positive lymph nodes and lymphatic invasion are significant prognostic factors after pancreaticoduodenectomy for distal cholangiocarcinoma. Clinical and Experimental Gastroenterology, 12, 255-262.

Søreide, K., Guest, R. V., Harrison, E. M., Kendall, T. J., Garden, O. J., & Wigmore, S. J. (2019). Systematic review of management of incidental gallbladder cancer after cholecystectomy. British Journal of Surgery, 106(1), 32-45.

Valle, J. W., Kelley, R. K., Nervi, B., Oh, D. Y., & Zhu, A. X. (2021). Biliary tract cancer. Lancet, 397(10272), 428-444.

Valle, J., Wasan, H., Palmer, D. H., Cunningham, D., Anthoney, A., Maraveyas, A., Madhusudan, S., Iveson, T., ... Bridgewater, J. (2010). Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. New England Journal of Medicine, 362(14), 1273-81.

van Vugt, J. L. A., Gaspersz, M. P., Coelen, R. J. S., Vugts, J., Labeur, T. A., de Jonge, J., Polak, W. G., Busch, O. R. C., ... Groot Koerkamp, B. (2018). The prognostic value of portal vein and hepatic artery involvement in patients with perihilar cholangiocarcinoma. HPB, 20(1), 83-92.

Van Eecke, E., Degroote, H., Vanlander, A., & Hindryckx, P. (2022). Outcome of primary ERCP versus primary PTC for biliary drainage in malignant hilar biliary strictures: a systematic review and meta-analysis. Surgical Endoscopy, 36(10), 7160-7170.

van Keulen, A. M., Büttner, S., Erdmann, J. I., Hagendoorn, J., Hoogwater, F. J. H., JNM, I. J., Neumann, U. P., Polak, W. G., ... Koerkamp, B. G. (2023). Major complications and mortality after resection of intrahepatic cholangiocarcinoma: A systematic review and meta-analysis. Surgery, 173(4), 973-982.

Vogel, A., Bridgewater, J., Edeline, J., Kelley, R. K., Klümpen, H. J., Malka, D., Primrose, J. N., Rimassa, L., ... Ducreux, M. (2023). Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology, 34(2), 127-140.

Weber, S. M., Ribero, D., O'Reilly, E. M., Kokudo, N., Miyazaki, M., & Pawlik, T. M. (2015). Intrahepatic cholangiocarcinoma: expert consensus statement. HPB, 17(8), 669-80.

Westphalen, C. B., Krebs, M. G., Le Tourneau, C., Sokol, E. S., Maund, S. L., Wilson, T. R., Jin, D. X., Newberg, J. Y., ... de Braud, F. (2021). Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population. NPJ precision oncology, 5(1), 69.

Wiggers, J. K., Groot Koerkamp, B., Cieslak, K. P., Doussot, A., van Klaveren, D., Allen, P. J., Besselink, M. G., Busch, O. R., ... Jarnagin, W. R. (2016). Postoperative Mortality after Liver Resection for Perihilar Cholangiocarcinoma: Development of a Risk Score and Importance of Biliary Drainage of the Future Liver Remnant. Journal of the American College of Surgeons, 223(2), 321-331.e1.

Zhang, X. F., Chakedis, J., Bagante, F., Chen, Q., Beal, E. W., Lv, Y., Weiss, M., Popescu, I., ... Pawlik, T. M. (2018). Trends in use of lymphadenectomy in surgery with curative intent for intrahepatic cholangiocarcinoma. British Journal of Surgery, 105(7), 857-866.

Zhou, R., Lu, D., Li, W., Tan, W., Zhu, S., Chen, X., Min, J., Shang, C., & Chen, Y. (2019). Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysis. HPB, 21(7), 784-792.

Zhu, A. X., Macarulla, T., Javle, M. M., Kelley, R. K., Lubner, S. J., Adeva, J., Cleary, J. M., Catenacci, D. V. T., ... Abou-Alfa, G. K. (2021). Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial. JAMA oncology, 7(11), 1669-1677.